827
Views
59
CrossRef citations to date
0
Altmetric
Clinical Features

Weight Considerations in Psychotropic Drug Prescribing and Switching

, MD & , MD
Pages 117-129 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Wade Marteene, Karl Winckel, Sam Hollingworth, Steve Kisely, Erin Gallagher, Margaret Hahn, Bjørn H Ebdrup, Joseph Firth & Dan Siskind. (2019) Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opinion on Drug Safety 18:12, pages 1149-1160.
Read now
Sidra Mahmood, Shahzad Hussain, Taufeeq ur Rehman, Corrado Barbui, Amanj Baker Kurdi & Brian Godman. (2019) Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future. Current Medical Research and Opinion 35:1, pages 51-61.
Read now
Daniela Adamo, Michele Davide Mignogna, Giuseppe Pecoraro, Massimo Aria & Giulio Fortuna. (2018) Management of reticular oral lichen planus patients with burning mouth syndrome-like oral symptoms: a pilot study. Journal of Dermatological Treatment 29:6, pages 623-629.
Read now
Miroslav Hajda, Jan Prasko, Klara Latalova, Radovan Hruby, Marie Ociskova, Michaela Holubova, Dana Kamaradova & Barbora Mainerova. (2016) Unmet needs of bipolar disorder patients. Neuropsychiatric Disease and Treatment 12, pages 1561-1570.
Read now

Articles from other publishers (55)

Marianna Piras, Setareh Ranjbar, Nermine Laaboub, Claire Grosu, Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus & Chin Bin Eap. (2023) Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study. Schizophrenia Bulletin 49:1, pages 24-33.
Crossref
Daisy Duan, Lenise J. Kim, Jonathan C. Jun & Vsevolod Y. Polotsky. (2022) Connecting insufficient sleep and insomnia with metabolic dysfunction. Annals of the New York Academy of Sciences 1519:1, pages 94-117.
Crossref
Wissam Ghusn, Celeste Bouchard, Mark A. Frye & Andres Acosta. (2022) Weight-centric treatment of depression and chronic pain. Obesity Pillars 3, pages 100025.
Crossref
Justin Tondt & Harold Edward Bays. (2022) Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2, pages 100017.
Crossref
Myung Hun Jung, Won-Myong Bahk, Young Sup Woo, Jong-Hyun Jeong, Bo-Hyun Yoon, Jeong Seok Seo, Chan-Mo Yang, Won Kim, Jung Goo Lee, Se-Hoon Shim, IL Han Choo, Sung-Yong Park, InKi Sohn, Duk-In Jon & Moon-Doo Kim. (2022) Korean Medication Algorithm Project for Bipolar Disorder 2022: Comorbid Physical Illnesses. Journal of Korean Neuropsychiatric Association 61:4, pages 267.
Crossref
Dan Rujescu, Stephan Röttig & Tim Johannes Krause. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1271 1280 .
Sue Shea, Christos Lionis, Chris Kite, Lou Atkinson, Surinderjeet S. Chaggar, Harpal S. Randeva & Ioannis Kyrou. (2021) Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. Biomedicines 9:11, pages 1697.
Crossref
Shira Weizman, Assaf Shelef, Esther Bloemhof Bris & Rafael Stryjer. (2021) A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia. Journal of Clinical Psychopharmacology 41:6, pages 629-631.
Crossref
Matthew J. Gurka, Siraj U. Siddiqi, Stephanie L. Filipp, Rebeccah Mercado, Lindsay A. Thompson, David M. Janicke & Elizabeth A. Shenkman. (2020) Attention deficit hyperactivity disorder medications and BMI trajectories: The role of medication type, sex and age . Pediatric Obesity 16:4.
Crossref
Geng-Ruei Chang, Po-Hsun Hou, Wei-Cheng Yang, Chao-Min Wang, Pei-Shan Fan, Huei-Jyuan Liao & To-Pang Chen. (2021) Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice. Pharmaceuticals 14:3, pages 267.
Crossref
Byron Alexander Foster, Kimberly Reynolds, Alicia Callejo-Black, Natasha Polensek & Beau C. Weill. (2021) Weight outcomes in children with developmental disabilities from a multidisciplinary clinic. Research in Developmental Disabilities 108, pages 103809.
Crossref
Hartej Gill, Barjot Gill, Sabine El‐Halabi, David Chen‐Li, Orly Lipsitz, Joshua Daniel Rosenblat, Tamsyn E. Van Rheenen, Nelson B. Rodrigues, Rodrigo B. Mansur, Amna Majeed, Leanna M. W. Lui, Flora Nasri, Yena Lee & Roger S. Mcintyre. (2020) Antidepressant Medications and Weight Change: A Narrative Review. Obesity 28:11, pages 2064-2072.
Crossref
Marcus May & Stefan Engeli. (2020) Gewichtsänderung als unerwünschte Arzneimittelwirkung. Adipositas - Ursachen, Folgeerkrankungen, Therapie 14:03, pages 133-139.
Crossref
Zhenzhen Chen, Xiangyang Liu, Yanjin Luo, Junpei Wang, Yuhong Meng, Lei Sun, Yongsheng Chang, Qinghua Cui & Jichun Yang. (2020) Repurposing Doxepin to Ameliorate Steatosis and Hyperglycemia by Activating FAM3A Signaling Pathway. Diabetes 69:6, pages 1126-1139.
Crossref
Svetlana Puzhko, Tibor Schuster, Tracie A. Barnett, Christel Renoux, Ellen Rosenberg, David Barber & Gillian Bartlett. (2020) Evaluating Prevalence and Patterns of Prescribing Medications for Depression for Patients With Obesity Using Large Primary Care Data (Canadian Primary Care Sentinel Surveillance Network). Frontiers in Nutrition 7.
Crossref
Barbara J. Limandri. (2020) Adverse Events, Drug Interactions, and Treatment Adherence. Journal of Psychosocial Nursing and Mental Health Services 58:2, pages 9-13.
Crossref
Anna M. Wasik, Aleksandra Gorostowicz, Dominika Dudek, Jarosław Woroń & Marcin Siwek. (2020) Obesity and the pharmacotherapy of bipolar disorder. Pharmacotherapy in Psychiatry and Neurology 35:3-4, pages 177-192.
Crossref
Marcus May, Christoph Schindler & Stefan Engeli. (2020) Modern pharmacological treatment of obese patients. Therapeutic Advances in Endocrinology and Metabolism 11, pages 204201881989752.
Crossref
Dan Rujescu, Stephan Röttig & Tim Johannes Krause. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 10 .
Christopher J. Nolan. 2020. Comorbidity. Comorbidity 79 114 .
Barbara J. Limandri. (2019) Physiological Measurements for Prescribing Psychotropic Medications. Journal of Psychosocial Nursing and Mental Health Services 57:8, pages 7-10.
Crossref
Anna Wasik, Anna Krupa & Marcin Siwek. (2019) Interactions of antidepressants, mood-stabilisers and antipsychotics with food. Pharmacotherapy in Psychiatry and Neurology 35:1, pages 51-74.
Crossref
Bobbi Jo H. Yarborough, Scott P. Stumbo, Julie A. Cavese, Micah T. Yarborough & Carla A. Green. (2019) Patient perspectives on how living with a mental illness affects making and maintaining healthy lifestyle changes. Patient Education and Counseling 102:2, pages 346-351.
Crossref
Nadja Freund, Chloe J. Jordan, Jodi L. Lukkes, Kevin J. Norman & Susan L. Andersen. (2018) Juvenile exposure to methylphenidate and guanfacine in rats: effects on early delay discounting and later cocaine-taking behavior. Psychopharmacology 236:2, pages 685-698.
Crossref
Ariana M. Chao, Thomas A. Wadden & Robert I. Berkowitz. (2019) Obesity in Adolescents with Psychiatric Disorders. Current Psychiatry Reports 21:1.
Crossref
Noreen A. Reilly-Harrington, Emily H. Feig & Jeff C. Huffman. (2018) Bipolar Disorder and Obesity: Contributing Factors, Impact on Clinical Course, and the Role of Bariatric Surgery. Current Obesity Reports 7:4, pages 294-300.
Crossref
Koen P. Grootens, Anna Meijer, Erwin G. Hartong, Bennard Doornbos, P. Roberto Bakker, Asmar Al Hadithy, Kirsten N. Hoogerheide, Frans Overmeire, Radboud M. Marijnissen & Henricus G. Ruhe. (2018) Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder. European Journal of Clinical Pharmacology 74:11, pages 1485-1489.
Crossref
Inmaculada BaezaElena de la SernaRosa Calvo-EscalonaJessica Merchán-NaranjoPamela Rodríguez-LatorreM. Carmen Martínez-CantareroPatricia AndrésJosé Angel AldaDaniel Muñoz-SamonsDaniel IlzarbeCelso ArangoJosefina Castro-Fornieles. (2018) One-Year Prospective Study of Liver Function Tests in Children and Adolescents on Second-Generation Antipsychotics: Is There a Link with Metabolic Syndrome?. Journal of Child and Adolescent Psychopharmacology 28:7, pages 463-473.
Crossref
K.K. Fjukstad, A. Engum, S. Lydersen, I. Dieset, N. Eiel Steen, O.A. Andreassen & O. Spigset. (2020) Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics. European Psychiatry 48:1, pages 71-78.
Crossref
Aaron Gluth, DeJuan White & Martha Ward. 2018. Lifestyle in Heart Health and Disease. Lifestyle in Heart Health and Disease 247 253 .
Xin Zou, Wenya Huang, Fuer Lu, Ke Fang, Dingkun Wang, Shuyong Zhao, Jiming Jia, Lijun Xu, Kaifu Wang, Nan Wang & Hui Dong. (2017) The effects of Jiao-Tai-Wan on sleep, inflammation and insulin resistance in obesity-resistant rats with chronic partial sleep deprivation. BMC Complementary and Alternative Medicine 17:1.
Crossref
A. A. Verhaegen & L. F. Van Gaal. (2017) Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. Journal of Endocrinological Investigation 40:11, pages 1165-1174.
Crossref
Cassandra Anne Suarez, Anne-Reet Ilves Annunziata & Johanna T. Dwyer. (2017) Nutrition for Persons Coping With Serious Mental Illnesses. Nutrition Today 52:4, pages 190-202.
Crossref
Sai IyerMaya KumarMichael I. ReiffMartin T. Stein. (2017) Inattentive Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Weight Loss in a 15-Year-Old Girl: Are We Enabling the Development of an Eating Disorder?. Journal of Developmental & Behavioral Pediatrics 38:1, pages S60-S62.
Crossref
Sarah B. Mathews & C. Neill Epperson. 2017. Essentials of Menopause Management. Essentials of Menopause Management 105 127 .
David A. Hart. (2016) Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female mice. Biology of Sex Differences 7:1.
Crossref
Katrine Kveli Fjukstad, Anne Engum, Stian Lydersen, Ingrid Dieset, Nils Eiel Steen, Ole A. Andreassen & Olav Spigset. (2016) Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder. Journal of Clinical Psychopharmacology 36:6, pages 615-620.
Crossref
J. L. Kuk & S. Wharton. (2016) Differences in weight change trajectory patterns in a publicly funded adult weight management centre. Obesity Science & Practice 2:2, pages 215-223.
Crossref
Samir Kumar Praharaj. (2016) Metformin for Lithium-induced Weight Gain: A Case Report. Clinical Psychopharmacology and Neuroscience 14:1, pages 101-103.
Crossref
Dennis Löffler, Kathrin Landgraf, Antje Körner, Jürgen Kratzsch, Kenneth Clifford Kirkby & Hubertus Himmerich. (2016) Modulation of triglyceride accumulation in adipocytes by psychopharmacological agents in vitro. Journal of Psychiatric Research 72, pages 37-42.
Crossref
Harold E. Bays, Peter H. Jones, Carl E. Orringer, W. Virgil Brown & Terry A. Jacobson. (2016) National Lipid Association Annual Summary of Clinical Lipidology 2016. Journal of Clinical Lipidology 10:1, pages S1-S43.
Crossref
Michael Huss, Wai Chen & Andrea G. Ludolph. (2015) Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe. Clinical Drug Investigation 36:1, pages 1-25.
Crossref
Hans F. Fuchs, Vanessa Laughter, Cristina R. Harnsberger, Ryan C. Broderick, Martin Berducci, Christopher DuCoin, Joshua Langert, Bryan J. Sandler, Garth R. Jacobsen, William Perry & Santiago Horgan. (2015) Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surgical Endoscopy 30:1, pages 251-258.
Crossref
Elia Creta, Chiara Fabbri & Alessandro Serretti. (2015) Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder. Pharmacogenetics and Genomics 25:7, pages 354-362.
Crossref
Leonore M. de Wit, Annemieke van Straten, Femke Lamers, Pim Cuijpers & Brenda W.J.H. Penninx. (2015) Depressive and anxiety disorders: Associated with losing or gaining weight over 2 years?. Psychiatry Research 227:2-3, pages 230-237.
Crossref
Marcus May & Stefan Engeli. (2015) Besonderheiten der Pharmakotherapie adipöser Patienten. CardioVasc 15:3, pages 45-50.
Crossref
Andreas Palm, Christer Janson & Eva Lindberg. (2015) The impact of obesity and weight gain on development of sleep problems in a population-based sample. Sleep Medicine 16:5, pages 593-597.
Crossref
Agnese Marsano, Stefano Porcelli, Alessandro Serretti & Paolo Scudellari. (2015) Il trattamento antidepressivo: effetti sul peso corporeo. L'Endocrinologo 16:1, pages 22-25.
Crossref
Thomas R. Smith, Mei T. Liu & Megan E. Maroney. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 33 44 .
Massimo Cuzzolaro. 2015. Multidisciplinary Approach to Obesity. Multidisciplinary Approach to Obesity 193 203 .
Ching-I Hung, Chia-Yih Liu, Mei-Chun Hsiao, Nan-Wen Yu & Chun-Lin Chu. (2014) Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders. BMC Psychiatry 14:1.
Crossref
H. M. Savignac, B. Kiely, T. G. Dinan & J. F. Cryan. (2014) Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice . Neurogastroenterology & Motility 26:11, pages 1615-1627.
Crossref
Harold E. Bays, Peter H. Jones, W. Virgil Brown & Terry A. Jacobson. (2014) National Lipid Association Annual Summary of Clinical Lipidology 2015. Journal of Clinical Lipidology 8:6, pages S1-S36.
Crossref
Deepmala & Mayank Agrawal. (2014) Use of Propranolol for Hypersexual Behavior in an Adolescent With Autism. Annals of Pharmacotherapy 48:10, pages 1385-1388.
Crossref
Maarten Bak, Annemarie Fransen, Jouke Janssen, Jim van Os & Marjan Drukker. (2014) Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis. PLoS ONE 9:4, pages e94112.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.